¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neu"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • neuromuscular dysfunction
    ½Å°æ±Ù(À°)±â´ÉÀÌ»ó
  • neuromuscular junction
    ½Å°æ±Ù(À°)ÀÌÀ½ºÎ
  • neuromuscular monitoring
    ½Å°æ±Ù(À°)°¨½Ã
  • neuromuscular receptor
    ½Å°æ±Ù(À°)¼ö¿ëü
  • neuromuscular spindle
    ½Å°æ±Ù(À°)¹æÃß
  • neuromuscular synapse
    ½Å°æ±Ù(À°)½Ã³À½º, ½Å°æ±Ù(À°)¿¬Á¢
  • neuromuscular transmission
    ½Å°æ±Ù(À°)Àü´Þ
  • neuromyelitis
    ½Å°æÃ´¼ö¿°
  • neuromyelitis optica
    ½Ã(°¢)½Å°æÃ´¼ö¿°
  • neuromyopathic
    ½Å°æ±Ù(À°)º´(Áõ)-
  • neuromyopathy
    ½Å°æ±Ù(À°)º´(Áõ)
  • neuromyositis
    ½Å°æ±Ù(À°)¿°
  • neuron
    1. ½Å°æ¼¼Æ÷ 2. ´º·±, ½Å°æ¿ø
  • neuron-specific enolase
    ´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
  • neuronitis
    ½Å°æ¼¼Æ÷¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • neuronophage
    ½Å°æÆ÷½Ä¼¼Æ÷
  • neuronophagia
    ½Å°æÆ÷½ÄÇö»ó
  • neuroparalytic keratitis
    ½Å°æ¸¶ºñ°¢¸·¿°
  • neuroparalytic keratopathy
    ½Å°æ¸¶ºñ°¢¸·º´Áõ
  • neuropathic
    ½Å°æº´Áõ-
  • neuropathic arthropathy
    ½Å°æº´°üÀýº´Áõ
  • neuropathic diathesis
    ½Å°æº´Ã¼Áú
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • neuropathogenesis
    ½Å°æº´¹ß»ý, ½Å°æº´¹ßº´·Ð
  • neuropathology
    ½Å°æº´¸®ÇÐ
  • neuropathy
    ½Å°æº´Áõ
  • neuropeptide
    ½Å°æÆéƼµå
  • neuropharmacology
    ½Å°æ¾à¸®ÇÐ
  • neurophilic
    (¢¡neurotropic) ½Å°æÄ£È­-,
  • neurophysiological study
    ½Å°æ»ý¸®ÇÐÀû°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
  • neurodynamia
    ½Å°æ¿¡³ÊÁö, ½Å°æ·Â(ãêÌèæ³).
  • neurodynia
    ½Å°æÅë(ãêÌè÷Ô).
  • neurodystonia
    ½Å°æÀ̱äÀåÁõ.
  • neuroectoderm
    ½Å°æ¿Ü¹è¿±(~èâÛÏç¨).
  • neuroectodermal junction
    ½Å°æ¿Ü¹è¿±¿¬°á
  • neuroectodermal tumor
    ½Å°æ¿Ü¹è¿±Á¾¾ç(¡­èâÛÏç¨ðþåË)
  • neuroeffector junction
    ½Å°æÈ¿°ú±âÁ¢ÇÕºÎ(~üùÍýÐïïÈùêÝ»).
  • neuroelectricity
    ½Å°æÀü±â(~ï³Ñ¨).
  • neuroendocrine
    ½Å°æ³»ºÐºñ(ÀÇ).
  • neuroendocrine
    ½Å°æ ³»ºÐºñ(ÀÇ)
  • neuroendocrine carcinoma
    ½Å°æ ³»ºÐºñ¼º ¾Ï
  • neuroendocrine cells
    ½Å°æ³»ºÐºñ¼¼Æ÷(¡­Ò®ÝÂÝôá¬øà)
  • neuroendocrine system =neurosecretory
    ½Å°æ³»ºÐºñ°è(~Ò®ÝÂù²Í§).
  • neuroendocrine system =neurosecretory s.
    ½Å°æ³»ºÐºñ°è(~Ò®ÝÂù²Í§).
  • neuroendocrine tumors
    ½Å°æ³»ºÐºñÁ¾(¡­Ò®ÝÂÝôðþ)
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
  • JrId: 8285
    JournalTitle: Neuroscience research communications.
    MedAbbr: Neurosci Res Commun
    ISSN: 0893-6609
    ESSN:
    IsoAbbr: Neurosci. Res. Commun.
    NlmId: 8804150
  • JrId: 8581
    JournalTitle: a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
    MedAbbr: Neurodegeneration
    ISSN: 1055-8330
    ESSN:
    IsoAbbr:
    NlmId: 9209022
  • JrId: 8737
    JournalTitle: Neuroimmunomodulation.
    MedAbbr: Neuroimmunomodulation
    ISSN: 1021-7401
    ESSN:
    IsoAbbr: Neuroimmunomodulation
    NlmId: 9422763
  • JrId: 8761
    JournalTitle: Neurobiology of learning and memory.
    MedAbbr: Neurobiol Learn Mem
    ISSN: 1074-7427
    ESSN:
    IsoAbbr:
    NlmId: 9508166
  • JrId: 20127
    JournalTitle: Neurotoxins.
    MedAbbr: Neurotoxins
    ISSN: 1357-7115
    ESSN:
    IsoAbbr:
    NlmId: 9508903
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • neurosecretory material
    ½Å°æ ºÐºñ ¹°Áú
  • neurosensory symptom
    °¨°¢ ½Å°æ¼º Áõ»ó
  • neurostatus
    º´·Â¿¡ À־ÀÇ ½Å°æ ¡ÈÄ
    ȯÀÚÀÇ º´·Â¿¡ À־ ½Å°æ Áõ»óÀÇ »óÅÂ.
  • neurosurgical anesthesia
    ½Å°æ ¿Ü°ú ¸¶Ãë
  • neurosyphilis
    ½Å°æ ¸Åµ¶
    µ¿ÀǾî=neuroleus. ÁßÃ߽Űæ°èÀÇ ¸Åµ¶. ³ú¸· Ç÷°ü¼º ¸Åµ¶, ô¼ö·Î, ¹× Àü½Å ¸¶ºñ Áß ÇÑ °¡Áö ÇüŸ¦ ³ªÅ¸³½´Ù. ¶ÇÇÑ Ã´¼ö ¸Åµ¶À¸·Î ÀÎÇÑ ¿îµ¿ ½ÇÁ¶ ataxia¿Í °¨°¢ ¼Ò½Ç ¶§¹®¿¡ ½½ °üÀýÀÇ ÅðÇ༺ ÆÄ±«¼º °üÀý¿°ÀÌ À¯¹ßµÇ±âµµ Çϴµ¥ À̸¦ »þ¸£ÄÚ °üÀýÀ̶ó°í ÇÑ´Ù. Ä¡·á¹ÞÁö ¾ÊÀº ȯÀÚÀÇ ¾à 10% ¹Ì¸¸¿¡¼­ ¹ßÇàÇϸç ÁÖ·Î Á¦ 3±â¿¡ ³ªÅ¸³­´Ù.
  • neuroterminal
    ½Å°æ ¸»´Ü
    µ¿ÀǾî=end-organ. ¸»ÃʽŰæÀÇ Á¾¸»±â.
  • neurothele
    ½Å°æ À¯µÎ
    ÁøÇÇÀÇ °¨°¢¼º ½Å°æ À¯µÎ.
  • neurotic
    ½Å°æÁõÀÇ, ½Å°æ¼ºÀÇ, ½Å°æÁõÀû
    1. ½Å°æÁõ
  • neurotic anxiety
    ½Å°æÁõÀû ºÒ¾È
  • neurotic disorder
    ½Å°æÁõÀû Àå¾Ö
  • neurotic patient
    ½Å°æÁõ ȯÀÚ
  • neuroticism
    ½Å°æÁú
    µµÂøµÈ ¶Ç´Â °úÀ×ÀÇ ½Å°æ ÀÛ¿ëÀÇ »óÅÂ.
  • neurotization
    ½Å°æ Àç»ý, ½Å°æ À̽ļú, ½Å°æ ±â´É ȸº¹
    ¸¶ºñµÈ ±ÙÀ°¿¡ ½Å°æÀ» À̽ÄÇÏ´Â ¹æ¹ý.
  • neurotome
    ½Å°æ Àý¸®µµ, ½Å°æ Àý°³µµ, ½Å°æ ºÐÀý
    1. ½Å°æÀ» Àý°³Çϴ ħ»óµµ. 2. ½Å°æ ºÐÀý.
  • neurotomy
    ½Å°æ Àý¸®¼ú, ½Å°æ Àý´Ü¼ú
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 13
neurofibrillary degeneration Formation of coarse, argentophilic, intracytoplasmic fibres, often in complex tangles within intracranial nerve cells that are undergoing aging.
See: Alzheimer's disease.
(05 Mar 2000)
neurofibrillary tangle <cell biology> Accumulation of twisted protein fragments inside nerve cells. Neurofibrillary tangles are one of the characteristic structural abnormalities found in the brains of patients with Alzheimer's disease patients.
Upon autopsy, the presence of neuritic plaquesand neurofibrillary tangles is used to positively diagnose Alzheimer's disease.
(22 May 1997)
neurofibrillary tangles Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments (neurofilaments and microtubules). These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: 1) the intermediate filaments: medium- and high-molecular-weight neurofilaments; 2) the microtubule-associated proteins map-2 and tau; 3) actin; and 4) ubiquitin. As one of the hallmarks of alzheimer disease, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brainstem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of alzheimer disease.
(12 Dec 1998)
neurofibrils <cell biology> Filaments found in neurons, not necessarily neurofilaments in all cases and in the older literature fibrils are composed of both microtubules and neurofilaments. Originally used by light microscopists to describe much larger fibrils seen particularly well with silver staining methods.
(18 Nov 1997)
neurofibroma <oncology, tumour> A neurofibroma is a smooth, polypoid, soft or firm tumour that arises from the Schwann cells and fibroblasts of the neurilemmal sheath. They may grow anywhere in the myelinated nervous system.
(27 Sep 1997)
neurofibroma, plexiform A type of neurofibroma representing an anomaly rather than a true neoplasm, in which the proliferation of schwann cells occurs from the inner aspect of the nerve sheath, thereby resulting in an irregularly thickened, distorted, tortuous structure. In some instances the process extends along the course of the nerve and may eventually involve the spinal roots and the spinal cord.
(12 Dec 1998)
neurofibromatosis <oncology> One of the most common disorders in genetics, neurofibromatosis encompasses at least two diseases, designated NF-1 and NF-2.
NF-1 or classic neurofibromatosis, is characterised by the familiar cafe- au-lait spots, axillary freckling, cutaneous and visceral neurofibromas (which sometimes undergo malignant transformation), gliomas, scoliosis, and Lisch nodules of the iris. NF-1 is associated with the the von Recklinghausen Neurofibromatosis locus that encodes the NF-1 protein, a GTPase activating protein which interacts with the ras proteins. The gene is located on chromosome 17.
NF-2, also called acoustic or central neurofibromatosis, features neurofibromas restricted to the acoustic nerve (usually bilateral) and the central nervous system, skin lesions may or may not be present. The gene is located on chromosome 22.
There are no biochemical markers of the disorder, but the cloning of both the NF-1 and NF-2 genes makes DNA-based diagnosis possible in some families. Both genes appear to be tumour suppressor genes. Both conditions are autosomal dominant, but the variable penetrance and expressivity and high frequency of new mutations make genetic counseling difficult.
Inheritance: autosomal dominant.
(29 Dec 1997)
neurofibromatosis 1 A congenital autosomal dominant disorder characterised by developmental changes in the nervous system, muscles, bones, and skin especially in those derived from the embryonic neural crest. There are multiple cutaneous tumours and tumours of the peripheral and central nervous system. The disease has been linked to mutations of the nf1 gene on chromosome 17.
(12 Dec 1998)
neurofibromatosis 2 Severe autosomal dominant disorder characterised especially by bilateral acoustic neuromas as well as other multiple tumours including meningiomas, ependymomas, spinal neurofibromas, and gliomas. The disease has been linked to mutations of the nf2 gene on chromosome 22.
(12 Dec 1998)
neurofibrosarcoma A malignant tumour of neural sheath origin. Although superficially similar in appearance to fibrosarcoma, it is more aggressive and its cells are more variable in size and shape. The most common primary sites are the extremities, retroperitoneum, and trunk. It accounts for 5-10% of all non-rhabdomyosarcomatous soft tissue sarcomas in children. Neurofibrosarcoma often occurs in association with von recklinghausen's disease.
(12 Dec 1998)
neurofilament <cell biology> Member of the class of intermediate filaments found in axons of nerve cells.
In vertebrates assembled from three distinct protein subunits. (neurofilament L, 68 kD, neurofilament M, 160 kD, & neurofilament H 200 kD) These proteins, if introduced into fibroblasts, will incorporate into the vimentin filament system.
(29 Dec 1997)
neurofilament proteins Type III intermediate filament proteins that assemble into neurofilaments, the major cytoskeletal element in nerve axons and dendrites. They consist of three distinct polypeptides, the neurofilament triplet. Types I, II, and IV intermediate filament proteins form other cytoskeletal elements such as keratins and lamins. It appears that the metabolism of neurofilaments is disturbed in alzheimer's disease, as indicated by the presence of neurofilament epitopes in the neurofibrillary tangles, as well as by the severe reduction of the expression of the gene for the light neurofilament subunit of the neurofilament triplet in brains of alzheimer's patients. (can j neurol sci 1990 aug;17(3):302)
(12 Dec 1998)
neurofilament-associated kinase <enzyme> Phosphorylates a subset of peptides in vitro which are phosphorylated in vivo in cultured neurons
Registry number: EC 2.7.1.-
Synonym: naf kinase
(26 Jun 1999)
neuroganglion 1. A knot or knotlike mass.
2. <anatomy> A general term for a group of nerve cell bodies located outside the central nervous system, occasionally applied to certain nuclear groups within the brain or spinal cord, for example basal ganglia.
3. <oncology, tumour> A benign cystic tumour occurring on a aponeurosis or tendon, as in the wrist or dorsum of the foot, it consists of a thin fibrous capsule enclosing a clear mucinous fluid.
(18 Nov 1997)
neurogastric Relating to the innervation of the stomach.
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 13
  • Neurogranin - »õâ A BRAIN-specific substrate for PROTEIN KINASE C that binds CALMODULIN and is involved in regulation of CALCIUM SIGNALING.
    Synonyms : P17 Protein Kinase C Substrate, RC3 Protein (Neurogranin)
  • Neuroimmunomodulation - »õâ The biochemical and electrophysiological interactions between the NERVOUS SYSTEM and IMMUNE SYSTEM that result in regulation of the immune system by the nervous system.
    Synonyms : Neuroimmune Mechanisms, Neuroimmune Process, Mechanism, Neuroimmune, Mechanisms, Neuroimmune, Neuroimmune Mechanism, Process, Neuroimmune
  • Neurokinin A - »õâ A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.
    Synonyms : Neurokinin alpha, Neuromedin L
  • Neurokinin B - »õâ A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ A with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the URINARY BLADDER and UTERUS.
    Synonyms : Neurokinin beta
  • Neuroleptanalgesia - »õâ A form of analgesia accompanied by general quiescence and psychic indifference to environmental stimuli, without loss of consciousness, and produced by the combined administration of a major tranquilizer (neuroleptic) and a narcotic.
    Synonyms : Neuroleptoanalgesia
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 13
neurosarcoma a malignant neoplasm of nerve tissue and fibrous tissue and connective tissue
Ãâó: wordnet.princeton.edu/perl/webwn
neuronal neural: of or relating to neurons; "neural network"
Ãâó: wordnet.princeton.edu/perl/webwn
neuroscience the scientific study of the nervous system
Ãâó: wordnet.princeton.edu/perl/webwn
neurasthenia nervous breakdown (not in technical use)
Ãâó: wordnet.princeton.edu/perl/webwn
neurasthenic a person suffering a nervous breakdown of or relating to or suffering from neurasthenia; "neurasthenic tendencies"
Ãâó: wordnet.princeton.edu/perl/webwn
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 4 ÆäÀÌÁö: 13
neu a star that has collapsed under its own gravity
neu leukopenia in which the decrease is primarily in number of neutrophils (the chief phagocytic leukocyte)
neu the chief phagocytic leukocyte
neu the chief phagocytic leukocyte
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 13
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 13
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 13
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 13
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 13
ÅëÇÕ°Ë»ö ¿Ï·á